Canadian cannabis companies look overseas as domestic market saturates
Facing a saturated market and intense competition domestically, Canadian cannabis companies are exporting more of their products overseas.
Facing a saturated market and intense competition domestically, Canadian cannabis companies are exporting more of their products overseas.
Expanding a marijuana brand across international markets is a thrilling and challenging endeavor.
Co-founder Jürgen Bickel discusses Storz & Bickel’s rigorous testing protocols, the growth of Germany’s medical cannabis market and potential policy ramifications under the country’s newly elected conservative party.
Canada-based cannabis retailer High Tide is stepping back from its deal with Purecan GmbH to enter Germany’s medical marijuana market.
Conservative leader Friedrich Merz’s election victory in Germany could result in a potential slowdown or reversal of the European Union nation’s recent cannabis reform as his party has previously opposed legalization efforts.
German voters will decide Feb. 23 between the Social Democratic Party and the Christian Democratic Union. If voters choose the CDU, cannabis reforms could slow or even be reversed.
Australia’s medical cannabis revenue is expected to grow from around $600 million (AU$955.1 million) in 2024 to more than $1.2 billion by 2028, according to a new report.